rs55700371
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP2PP3
The NM_003995.4(NPR2):c.2644G>A(p.Val882Ile) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000179 in 1,612,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003995.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- acromesomelic dysplasia 1, Maroteaux typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- short stature with nonspecific skeletal abnormalities 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- tall stature-scoliosis-macrodactyly of the great toes syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NPR2 | NM_003995.4 | c.2644G>A | p.Val882Ile | missense_variant, splice_region_variant | Exon 18 of 22 | ENST00000342694.7 | NP_003986.2 | |
| NPR2 | NM_001378923.1 | c.2653G>A | p.Val885Ile | missense_variant, splice_region_variant | Exon 18 of 22 | NP_001365852.1 | ||
| NPR2 | XM_047423431.1 | c.1249G>A | p.Val417Ile | missense_variant, splice_region_variant | Exon 13 of 17 | XP_047279387.1 | ||
| NPR2 | XM_024447561.2 | c.1240G>A | p.Val414Ile | missense_variant, splice_region_variant | Exon 13 of 17 | XP_024303329.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000127 AC: 32AN: 251488 AF XY: 0.000169 show subpopulations
GnomAD4 exome AF: 0.000183 AC: 267AN: 1460250Hom.: 0 Cov.: 31 AF XY: 0.000186 AC XY: 135AN XY: 726592 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000145 AC: 22AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74316 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Acromesomelic dysplasia 1, Maroteaux type Uncertain:1
This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PP3. -
Acromesomelic dysplasia 1, Maroteaux type;C4014690:Tall stature-scoliosis-macrodactyly of the great toes syndrome Uncertain:1
This sequence change replaces valine with isoleucine at codon 882 of the NPR2 protein (p.Val882Ile). The valine residue is highly conserved and there is a small physicochemical difference between valine and isoleucine. This variant is present in population databases (rs55700371, ExAC 0.03%). This variant has not been reported in the literature in individuals with NPR2-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 36373817, 35741827) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at